Virax Biolabs Expands Mpox Test Distribution Agreement with Cosmos Health
Virax Biolabs extended its distribution agreement with Cosmos Health to commercialize its Mpox kits in the Gulf Cooperation Council.
Read MorePosted by Andy Lundin | Sep 16, 2024 | Emerging & Zoonotic Diseases |
Virax Biolabs extended its distribution agreement with Cosmos Health to commercialize its Mpox kits in the Gulf Cooperation Council.
Read MorePosted by Andy Lundin | Sep 13, 2024 | Cardiovascular |
A new review finds that 20% of the global population carries a genetic risk for cardiovascular diseases due to high levels of lipoprotein(a).
Read MorePosted by Andy Lundin | Sep 12, 2024 | Digital Pathology |
Proscia’s AI-powered digital pathology software enhances pathologists’ ability to deliver more precise and efficient cancer diagnoses.
Read MorePosted by Andy Lundin | Sep 9, 2024 | Diagnostic Technologies |
Researchers developed machine learning models to diagnose pediatric inflammatory conditions by analyzing cell-free RNA in blood plasma.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Cancer, Histology |
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read More